S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
Free Trial
NYSE:PTHN

Patheon N.V. Ordinary shares, p (PTHN) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free PTHN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$34.98
▼
$34.98
50-Day Range
N/A
52-Week Range
$23.72
▼
$35.13
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
PTHN stock logo

About Patheon N.V. Ordinary shares, p Stock (NYSE:PTHN)

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.

PTHN Stock News Headlines

April 15, 2024 | money.usnews.com
Cloudflare Inc - Ordinary Shares - Class A
March 19, 2024 | money.usnews.com
Chain Bridge I - Ordinary Shares - Class A
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 28, 2024 | nasdaq.com
Yandex N.V. Class A Ordinary Shares (YNDX)
February 27, 2024 | money.usnews.com
Aon plc. - Ordinary Shares - Class A
February 23, 2024 | morningstar.com
The Kingfish Co NV Ordinary Shares KING
February 21, 2024 | money.usnews.com
Kinder Morgan Inc - Ordinary Shares - Class P
February 14, 2024 | morningstar.com
JDE Peets NV Ordinary Shares
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
December 12, 2023 | nasdaq.com
Eaton Corporation, PLC Ordinary Shares (ETN)
December 2, 2023 | morningstar.com
Iveco Group NV Ordinary Shares
November 14, 2023 | finance.yahoo.com
Patheon N.V. Ordinary shares, p (PTHN)
November 13, 2023 | lse.co.uk
Ease2pay Nv Share Price (EAS2P.AM)
November 11, 2023 | lse.co.uk
New Amsterdam Invest N.v. Ordinary Shares Share Chat
October 29, 2023 | morningstar.com
InPoint Commercial Real Estate Income Inc Ordinary Shares - Class P
September 28, 2023 | morningstar.com
Wallbox NV Class A Ordinary Share
September 1, 2023 | money.usnews.com
Crowdstrike Holdings Inc - Ordinary Shares - Class A
August 16, 2023 | money.usnews.com
XPEL Inc - Ordinary Shares - Reg S
August 15, 2023 | morningstar.com
CureVac NV Ordinary Shares
August 4, 2023 | health.usnews.com
Keesha P. Kaplan
July 31, 2023 | nasdaq.com
Lifezone Metals Limited Ordinary Shares (LZM)
July 21, 2023 | uk.investing.com
FT Ordinary Share (FTII)
July 19, 2023 | nasdaq.com
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
June 28, 2023 | money.usnews.com
Comcast Corp - Ordinary Shares - Class A
June 19, 2023 | finance.yahoo.com
Improved Earnings Required Before RoodMicrotec N.V. (AMS:ROOD) Shares Find Their Feet
April 29, 2023 | morningstar.com
ZhongAn Online P&C Insurance Co Ltd Ordinary Shares - Class H
April 4, 2023 | thestreet.com
S&P, Moody's Shares Surge on Fraud Lawsuit Settlement
See More Headlines
Receive PTHN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Patheon N.V. Ordinary shares, p and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/08/2017
Today
4/19/2024
Fiscal Year End
10/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:PTHN
Previous Symbol
NASDAQ:PTHN
CUSIP
N/A
CIK
1643848
Web
www.patheon.com
Phone
31-20-622-3243
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Paul S. Levy
    Chairman of the Board
  • James C. Mullen
    Chief Executive Officer, Director
  • Stuart R. Grant
    Chief Financial Officer, Executive Vice President
  • Gilles A. Cottier
    President - Global Pharmaceutical Development Services
  • Franco Negron
    President - Drug Product Services
  • Lukas Utiger
    President - Drug Substance
  • Michael J. Lehmann
    Executive Vice President - Global Sales and Marketing
  • Michael E. Lytton J.D.
    Executive Vice President - Corporate Development and Strategy
  • Rebecca Holland New
    Chief Human Resources Officer and Executive Vice President - Communications and Project Management Office
  • Harry R. Gill III
    Senior Vice President - Quality and Continuous Improvement

Key Competitors

View All Competitors

PTHN Stock Analysis - Frequently Asked Questions

How were Patheon N.V. Ordinary shares, p's earnings last quarter?

Patheon N.V. Ordinary shares, p (NYSE:PTHN) released its quarterly earnings results on Thursday, June, 8th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.19 by $0.01. The business had revenue of $483.40 million for the quarter, compared to analysts' expectations of $466.08 million. The firm's quarterly revenue was up 3.2% on a year-over-year basis.

What other stocks do shareholders of Patheon N.V. Ordinary shares, p own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Patheon N.V. Ordinary shares, p investors own include SVB Financial Group (SIVB), Skyworks Solutions (SWKS), Wells Fargo & Company (WFC), Alexion Pharmaceuticals (ALXN), NXP Semiconductors (NXPI), Bank of the Ozarks (OZRK), Clearside Biomedical (CLSD), Coherus BioSciences (CHRS), Gemphire Therapeutics (GEMP) and JetBlue Airways (JBLU).

When did Patheon N.V. Ordinary shares, p IPO?

Patheon N.V. Ordinary shares, p (PTHN) raised $625 million in an IPO on Thursday, July 21st 2016. The company issued 30,500,000 shares at $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities served as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

This page (NYSE:PTHN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
How Biden has already won 2024
Porter & Company
My biggest AI fear
Paradigm Press